skip to main content


*Yeni Rohmaeni  -  Departement of Community Nutrition, IPB University, Indonesia
Hardinsyah Hardinsyah  -  Department of Community Nutrition, Faculty of Human Ecology, IPB University, Indonesia
Ikeu Tanziha  -  Department of Community Nutrition, Faculty of Human Ecology, IPB University, Indonesia
Received: 27 Nov 2022; Published: 24 Jun 2023.

Citation Format:


Background: Small dense low-density lipoprotein (sdLDL-C) is an atherogenic lipoprotein. Increased sdLDL-C concentration was hypothesized to be associated with obesity and diabetes mellitus (DM).

Objectives: The study aimed to determine the association between sdLDL-C, central obesity, and DM among Indonesian adults, controlled by personal and clinical parameters.

Materials and Methods: This study used secondary data from Basic Health Research 2013 of the Ministry of Health, which applied a cross-sectional study design. For this purpose, 30,548 subjects aged 19-79 were analyzed. The sdLDL-C was performed by using Sampson Formula derived from conventional lipid panels. As investigated by Sampson, the formula referred to cLDL-C (calculated LDL-C) and ElbLDL-C (estimated large buoyant LDL-C).

Results: There was a positive association between sdLDL-C and central obesity (OR: 3.94; 95% CI: 3.13-3.89), as well as sdLDL-C and DM status (OR: 1.98; 95% CI; 1.43-2.75) after adjusting the personal and clinical parameters.

Conclusion: This study demonstrated that the increment of sdLDL-C level and central obesity affected DM status in Indonesian adults. It implies that the sdLDL-C was a potential biomarker to assess the risk of DM.

Keywords: Central obesity, Diabetes mellitus, Hypertension, Indonesian adult, sdLDL-C


Note: This article has supplementary file(s).

Fulltext View|Download |  common.other
Type Other
  Download (598KB)    Indexing metadata
Keywords: Central obesity, Diabetes mellitus, Hypertension, Indonesian adult, sdLDL-C

Article Metrics:

  1. Kemenkes, “Laporan Riskesdas 2018,” 2018. (accessed Feb. 07, 2021)
  2. C. F. Lin, Y. H. Chang, S. C. Chien, Y. H. Lin, and H. Y. Yeh, “Epidemiology of Dyslipidemia in the Asia Pacific Region,” International Journal of Gerontology, vol. 12, no. 1. pp. 2–6, 2018. doi: 10.1016/j.ijge.2018.02.010
  3. P. Narindrarangkura, W. Bosl, R. Rangsin, and P. Hatthachote, “Prevalence of dyslipidemia associated with complications in diabetic patients: A nationwide study in Thailand,” Lipids Health Dis, vol. 18, no. 1, pp. 1–8, 2019, doi: 10.1186/s12944-019-1034-3
  4. A. al Maradni et al., “The effect of intensive lifestyle intervention on renal function in patients with diabetes and obesity in real-world practice: A 5-years longitudinal study,” Human Nutrition and Metabolism, vol. 24, no. 2021, p. 20019, 2021, doi: 10.1016/j.hnm.2021.200119
  5. Arnett et al., “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (Circulation (2019) 140 (e563-e595) DOI: 10,”Circulation,vol.74,no.10,pp.e177–e232,2020,doi: 10.1161/CIR.0000000000000754.
  6. N. Katta, T. Loethen, C. J. Lavie, and M. A. Alpert, “Obesity and Coronary Heart Disease: Epidemiology, Pathology, and Coronary Artery Imaging,” Current Problems in Cardiology, vol. 46, no. 3. p. 100655, 2021. doi: 10.1016/j.cpcardiol.2020.100655
  7. S. M. Grundy et al., “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/
  8. ASPC/NLA/PCNAGuideline on the Management of Blood Cholesterol,” J Am Coll Cardiol, vol. 73, no. 24, pp. e285–e350, 2019, doi: 10.1016/j.jacc.2018.11.003
  9. Virani et al., “Heart Disease and Stroke Statistics-2021 Update A Report from the American Heart Association,” Circulation, vol. 8, no. 2021, pp. e254–e743, 2021, doi: 10.1161/CIR.0000000000000950
  10. S. Tyrovolas et al., “Diabetes mellitus and its association with central obesity and disability among older adults: A global perspective,” Exp Gerontol, vol. 64, no. 2015, pp. 70–77, 2015, doi: 10.1016/j.exger.2015.02.010
  11. T. M. Powell-Wiley et al., “Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association,” Circulation, vol. 143, no. 21. pp. e984–e1010, 2021. doi: 10.1161/CIR.0000000000000973
  12. J. Guo, J. Li, K. Huang, N. Huang, and X. L. Feng, “Socio-economic inequalities in the chronic diseases management among Chinese adults aged 45 years and above: a cross sectional study,” Archives of Public Health, vol. 79, no. 1, pp. 1–13, 2021, doi: 10.1186/s13690-021-00678-1
  13. M. S. Mohamed-Yassin et al., “High prevalence of dyslipidaemia subtypes and their associated personal and clinical attributes in Malaysian adults: the REDISCOVER study,” BMC Cardiovasc Disord, vol. 21, no. 1, pp. 1–13, 2021, doi: 10.1186/s12872-021-01956-0
  14. J. Nuotio et al., “CVD risk factors and surrogate markers - Urban-rural differences,” Scand J Public Health, vol. 48, no. 7, pp. 752–761, 2020, doi: 10.1177/1403494819869816
  15. V. G. Athyros et al., “Diabetes and lipid metabolism,” Hormones, vol. 17, no. 1. pp. 61–67, 2018. doi: 10.1007/s42000-018-0014-8
  16. K. L. Bjornstad, R. Drews, Ph.D., Sonia Caprio, M.D., D. M. N. Gubitosi Klug, M.D., Ph.D., J. than, M.D., Bereket Tesfaldet, M.S., M. D. Tryggestad, M.D., Neil H. White, and Ph. D. and Philip Zeitler, M.D., “Long-Term Complications in Youth-Onset Type 2 Diabetes,” New England Journal of Medicine, vol. 385, no. 21, pp. 416–426, 2021, doi: 10.1056/nejmc2114053
  17. Y. C. Huang, P. Y. Chang, J. S. Hwang, and H. C. Ning, “Association of small dense low-density lipoprotein cholesterol in type 2 diabetics with coronary artery disease,” Biomed J, vol. 37, no. 6, pp. 375–379, 2014, doi: 10.4103/2319-4170.132883
  18. P. Liana, “Peran Small Dense Low Density Lipoprotein Terhadap Penyakit Kardiovaskular,” Jurnal Kedokteran dan Kesehatan, vol. 1, no. 1, pp. 67–72, 2014
  19. C. Kanonidou, “Small dense low-density lipoprotein: Analytical review,” Clinica Chimica Acta, vol. 520, no. 2021, pp. 172–178, 2021, doi: 10.1016/j.cca.2021.06.012
  20. C. Ji et al., “Estimated pulse wave velocity and cardiovascular events in Chinese,” Int J Cardiol Hypertens, vol. 7, no. 2020, p. 100063, 2020, doi: 10.1016/j.ijchy.2020.100063
  21. G. Li et al., “Small dense low density lipoprotein-cholesterol and cholesterol ratios to predict arterial stiffness progression in normotensive subjects over a 5-year period,” Lipids Health Dis, vol. 17, no. 1, pp. 1–10, 2018, doi: 10.1186/s12944-018-0671-2
  22. M. A. Hill et al., “Insulin resistance, cardiovascular stiffening and cardiovascular disease,” Metabolism: Clinical and Experimental, vol. 119. p. 154766, 2021. doi: 10.1016/j.metabol.2021.154766
  23. I. K. Mardia and Santi Syafril, “Correlation Between Small Dense Low-Density Lipoprotein and Risk Factor Cardiovascular on Obesity,” Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI), vol. 4, no. 2, pp. 77–82, Aug. 2022, doi: 10.32734/jetromi.v4i2.9504
  24. M. Sampson, A. Wolska, R. Warnick, D. Lucero, and A. T. Remaley, “A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test,” Clin Chem, vol. 67, no. 7, pp. 987–997, 2021, doi: 10.1093/clinchem/hvab048
  25. P. Srisawasdi et al., “Estimation of plasma small dense LDL cholesterol from classic lipid measures,” Am J Clin Pathol, vol. 136, no. 1, pp. 20–29, 2011, doi: 10.1309/AJCPLHJBGG9L3ILS
  26. A. Hendarto, “Small Dense Low Density Lipoprotein Sebagai Prediktor Risiko Penyakit Jantung Koroner pada Anak Lelaki Obes Pra-Pubertal,” Sari Pediatri, vol. 12, no. 3, pp. 197–203, 2016, doi: 10.14238/sp12.3.2010.197-203
  27. S. Driyah, L. BS, and K. DK, “Korelasi Kontrol Glikemik dengan HDL dan Small-Dense LDL pada Penderita Diabetes Melitus dengan Komplikasi Jantung Koroner di RSUP Dr. Kariadi Semarang, Jawa Tengah,” Jurnal Biotek Medisiana Indonesia, vol. 8, no. 1, pp. 67–75, 2019, doi: 10.22435/jbmi.v8i1.2585
  28. Kemenkes, “Laporan Riskesdas 2013,” 2013. (accessed Feb. 07, 2021)
  29. N. Geifman, R. Cohen, and E. Rubin, “Redefining meaningful age groups in the context of disease,” Age (Omaha), vol. 35, no. 6, 2013, doi: 10.1007/s11357-013-9510-6
  30. Ariawan Iwan, “Indeks Sosio-ekonomi Menggunakan Principal Component Analysis,” Jurnal Kesehatan Masyarakat Nasional, vol. 1, no. 2, pp. 83–87, 2006
  31. H. A. Saad, P. K. Low, R. Jamaluddin, and H. P. Chee, “Level of physical activity and its associated factors among primary healthcare workers in Perak, Malaysia,” Int J Environ Res Public Health, vol. 17, no. 16, p. 5947, 2020, doi: 10.3390/ijerph17165947
  32. M. Sampson et al., “A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients with Normolipidemia and/or Hypertriglyceridemia,” JAMA Cardiol, vol. 5, no. 5, pp. 540–548, 2020, doi: 10.1001/jamacardio.2020.0013
  33. W. T. Friedewald, R. I. Levy, D. S. Fredrickson, and A, “Estimationof the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge,” Clin Chem, vol. 18, no. 6, pp. 499–502, 1972
  34. Kemenkes, “Pedoman Gizi Seimbang Permenkes RI,” Pedoman Gizi Seimbang Permenkes RI, 2014, [Online]. Available:
  35. WHO, “Waist circumference and Waist- hip Ratio WHO Expert Consultation,” Eur J Clin Nutr, vol. 64, no. 1, 2010
  36. NCEP ATP III, “Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.,” Circulation, vol. 106, no. 25, pp. 3143–42, 2002, doi: 10.1161/circ.106.25.3143
  37. K. Kene et al., “Prevalence and determinants of Impaired Serum Creatinine and Urea among type 2 diabetic patients of jimma medical center, Jimma, Southwestern Ethiopia, 2019,” Endocrine and Metabolic Science, vol. 3, no. 2021, p. 100096, 2021, doi: 10.1016/j.endmts.2021.100096
  38. T.Unger et al., “2020 International Society of Hypertension Global Hypertension Practice Guidelies,” Hypertension, vol. 75, no. 6, pp. 1334–1357, 2020, doi: 10.1161/HYPERTENSIONAHA.120.15026
  39. ADA, “2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021,” Diabetes Care, vol. 44, no. Supl 1, pp. S15–S33, 2021, doi: 10.2337/dc21-S002
  40. T. Izumida, Y. Nakamura, Y. Sato, and S. Ishikawa, “Association among age, gender, menopausal status and small dense low-density lipoprotein cholesterol: a cross-sectional study,” BMJ Open, vol. 11, no. 2, p. e041613, 2021, doi: 10.1136/bmjopen-2020-041613
  41. E. K. Duran, A. W. Aday, N. R. Cook, J. E. Buring, P. M. Ridker, and A. D. Pradhan, “Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease,” J Am Coll Cardiol, vol. 75, no. 17, pp. 2122–2135, 2020, doi: 10.1016/j.jacc.2020.02.059
  42. C. S. Thambiah and L. C. Lai, “Diabetic dyslipidaemia,” Practical Laboratory Medicine, vol. 26, no. 2021. p. e00248, 2021. doi: 10.1016/j.plabm.2021.e00248
  43. Erwinanto et al., Pedoman Tatalaksana Dislipidemia 2017, vol. 5, no. 1. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia, 2017
  44. D. Doupa et al., “Dyslipidemia, Obesity and other cardiovascular risk factors in the adult population in Senegal,” Pan African Medical Journal, vol. 19, no. 1, pp. 1–7, 2014, doi: 10.11604/pamj.2014.19.181.4872
  45. J. Fan et al., “Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation,” Nutr Metab (Lond), vol. 16, no. 1, pp. 1–9, 2019, doi: 10.1186/s12986-019-0334-y
  46. S. Kulanuwat, R. Tungtrongchitr, D. Billington, and I. G. Davies, “Prevalence of plasma small dense LDL is increased in obesity in a Thai population,” Lipids Health Dis, vol. 14, no. 1, pp. 1–8, Dec. 2015, doi: 10.1186/s12944-015-0034-1
  47. M. W. Freeman and G. A. Walford, “Lipoprotein Metabolism and the Treatment of Lipid Disorders,” in Endocrinology: Adult and Pediatric, vol. 1–2, United Kingdom: Saunders, 2015, pp. 788–807. doi: 10.1016/B978-0-323-18907-1.00041-X
  48. H. Arai et al., “Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: The suita study,” J Atheroscler Thromb, vol. 20, no. 2, pp. 195–203, 2013, doi: 10.5551/jat.14936
  49. M. Nakamura et al., “Relationships between smoking status, cardiovascular risk factors, and lipoproteins in a large japanese population,” J Atheroscler Thromb, vol. 28, no. 9, p. 56838, 2021, doi: 10.5551/jat.56838
  50. M. Lazo-Porras et al., “Urbanization, mainly rurality, but not altitude is associated with dyslipidemia profiles,” J Clin Lipidol, vol. 11, no. 5, pp. 1212–1222, 2017, doi: 10.1016/j.jacl.2017.06.016
  51. V. Mohan, R. Deepa, K. Velmurugan, and K. Gokulakrishnan, “Association of small dense LDL with coronary artery disease and diabetes in urban Asian Indians - The Chennai Urban Rural Epidemiology Study (CURES-8),” Journal of Association of Physicians of India, vol. 53, no. 2005, pp. 95–100, 2005
  52. N. S. M. Nor, S. A. R. Z. Ismail, and H. Nawawi, “Identifcation of cardiovascular risk factors among urban and rural Malaysian youths,” BMC Cardiovasc Disord, vol. 22, no. 70, pp. 1–10, 2022, doi:
  53. S. Kosaka, K. Suda, B. Gunawan, A. Raksanagara, C. Watanabe, and M. Umezaki, “Urban-rural difference in the determinants of dietary and energy intake patterns: A case study in west Java, Indonesia,” PLoS One, vol. 13, no. 5, May 2018, doi: 10.1371/journal.pone.0197626
  54. A. Atmarita, A. B. Jahari, S. Sudikno, and M. Soekatri, “Asupan Gula, Garam, Dan Lemak Di Indonesia: Analisis Survei Konsumsi Makanan Individu (SKMI) 2014,” Gizi Indonesia, vol. 39, no. 1, pp. 1–14, 2017, doi: 10.36457/gizindo.v39i1.201
  55. S. Wang et al., “Cigarette Smoking Is Negatively Associated with the Prevalence of Type 2 Diabetes in Middle-Aged Men with Normal Weight but Positively Associated with Stroke in Men,” J Diabetes Res, vol. 2019, no. 2019, pp. 1–8, 2019, doi: 10.1155/2019/1853018
  56. X. Hou et al., “Cigarette smoking is associated with a lower prevalence of newly diagnosed diabetes screened by OGTT than non-smoking in Chinese men with normal weight,” PLoS One, vol. 11, no. 3, p. 0149234, Mar. 2016, doi: 10.1371/journal.pone.0149234
  57. A. Chiolero, D. Faeh, F. Paccaud, and J. Cornuz, “Consequences of smoking for body weight, body fat distribution, and insulin resistance,” American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 801–809, 2008, doi: 10.1093/ajcn/87.4.801
  58. F. Fithra Dieny, S. Rose, A. Fahmy, and A. Tsani, “Body Mass Index is The Most Associated Anthropometry Indicators of Obesity with Insulin Resistance in Female College Students,” The Indonesian Journal of Nutrition) Jurnal Gizi Indonesia, vol. 11, no. 1, pp. 66–76, 2022
  59. P. Seoane-Collazo, C. Diéguez, R. Nogueiras, K. Rahmouni, J. M. Fernández-Real, and M. López, “Nicotine’ actions on energy balance: Friend or foe?,” Pharmacology and Therapeutics, vol. 219. Elsevier Inc., Mar. 01, 2021. doi: 10.1016/j.pharmthera.2020.107693
  60. Kotani, “The Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects,” J Clin Med Res, vol. 4, no. 3, p. 161, 2012, doi: 10.4021/jocmr870w
  61. D. D. Wang et al., “Fruit and Vegetable Intake and Mortality Results From 2 Prospective Cohort Studies of US Men and Women and a Meta-Analysis of 26 Cohort Studies,” Circulation, vol. 143, no. 17, pp. 1642–1654, Apr. 2021, doi: 10.1161/CIRCULATIONAHA.120.048996

Last update:

No citation recorded.

Last update: 2023-12-08 19:41:46

No citation recorded.